Intraperitoneal insulin delivery provides superior glycaemic regulation to subcutaneous insulin delivery in model predictive control-based fully-automated artificial pancreas in patients with type 1 diabetes: a pilot study.
Eyal DassauEric RenardJérôme PlaceAnne FarretMarie-José PelletierJustin LeeLauren M HuyettAnkush ChakrabartyFrancis J DoyleHoward C ZisserPublished in: Diabetes, obesity & metabolism (2017)
Glycaemic regulation with fully-automated AP delivering IP insulin was superior to that with SC insulin delivery. This pilot study provides proof-of-concept for an AP system combining a ZMPC algorithm with IP insulin delivery.